세계의 의약품 등급 카보머(Carbomers) 시장(2024-2028년)

The pharmaceutical grade carbomers market is forecasted to grow by USD 113.07 mn during 2023-2028, accelerating at a CAGR of 6.39% during the forecast period. The report on the pharmaceutical grade carbomers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surge in demand for topical drug delivery systems, increasing global geriatric population, and increasing incorporation of pharmaceutical grade carbomers in personal care and cosmetic products.

Technavio's pharmaceutical grade carbomers market is segmented as below:

By Application

• Dermal and topical
• Ophthalmic
• Oral care
• Others

By Type

• Carbomer 940
• Carbomer 980
• Carbomer 934
• Others

By Geographical Landscape

• APAC
• Europe
• North America
• South America
• Middle East and Africa

This study identifies the increasing focus on sustainable and eco-friendly manufacturing practices as one of the prime reasons driving the pharmaceutical grade carbomers market growth during the next few years. Also, rising need for bioadhesive drug delivery systems using pharmaceutical grade carbomers and growing adoption of hydrogels will lead to sizable demand in the market.

The report on the pharmaceutical grade carbomers market covers the following areas:

• Pharmaceutical grade carbomers market sizing
• Pharmaceutical grade carbomers market forecast
• Pharmaceutical grade carbomers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical grade carbomers market vendors that include 3V Sigma SpA, Anhui Newman Fine Chemicals Co. Ltd., Arihant Innochem Pvt. Ltd., Ashahi Chemical Industries Pvt. Ltd., Ashland Inc., Azelis SA, Berkshire Hathaway Inc., Corel Pharma Chem, East India Chemicals International, Evonik Industries AG, Golden Falcon General Trading LLC, Guangzhou Tinci Advanced Materials Co. Ltd., HENAN JINHE INDUSTRY CO. LTD., IMCD NV, JENE CHEMICALS, Libraw Pharma Excipients Pvt. Ltd., Maruti Chemicals, Merck KGaA, Muby Chemicals, Pioma Chemicals, Shreeji Pharma International, Sumitomo Seika Chemicals Co. Ltd., The SNF Group, Unilong Industry Co. Ltd, and Vizag Chemical International. Also, the pharmaceutical grade carbomers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global pharmaceutical grade carbomers market 2018 - 2022
• 4.2 Application Segment Analysis 2018 - 2022
• 4.3 Type Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Application

• 6.1 Market segments
• 6.2 Comparison by Application
• 6.3 Dermal and topical - Market size and forecast 2023-2028
• 6.4 Ophthalmic - Market size and forecast 2023-2028
• 6.5 Oral care - Market size and forecast 2023-2028
• 6.6 Others - Market size and forecast 2023-2028
• 6.7 Market opportunity by Application

7 Market Segmentation by Type

• 7.1 Market segments
• 7.2 Comparison by Type
• 7.3 Carbomer 940 - Market size and forecast 2023-2028
• 7.4 Carbomer 980 - Market size and forecast 2023-2028
• 7.5 Carbomer 934 - Market size and forecast 2023-2028
• 7.6 Others - Market size and forecast 2023-2028
• 7.7 Market opportunity by Type

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 APAC - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 North America - Market size and forecast 2023-2028
• 9.6 South America - Market size and forecast 2023-2028
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
• 9.8 US - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 UK - Market size and forecast 2023-2028
• 9.13 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 3V Sigma SpA
• 12.4 Anhui Newman Fine Chemicals Co. Ltd.
• 12.5 Arihant Innochem Pvt. Ltd.
• 12.6 Ashland Inc.
• 12.7 Azelis SA
• 12.8 Berkshire Hathaway Inc.
• 12.9 Corel Pharma Chem
• 12.10 Evonik Industries AG
• 12.11 Golden Falcon General Trading LLC
• 12.12 Guangzhou Tinci Advanced Materials Co. Ltd.
• 12.13 Maruti Chemicals
• 12.14 Merck KGaA
• 12.15 Sumitomo Seika Chemicals Co. Ltd.
• 12.16 The SNF Group
• 12.17 Unilong Industry Co. Ltd

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations